Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Puey Ling Chia

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 11, 2016
Severe Psoriasis Flare After Anti-Programmed Death Ligand 1 (PD-L1) Therapy for Metastatic Non-Small Cell Lung Cancer (NSCLC)Puey Ling Chia, Thomas John
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2018
Personalized Chemosensitivity Assays for Mesothelioma: Are They Worth the Effort?Thomas John, Puey Ling Chia
Expert Opinion on Drug Delivery|March 28, 2019
Epidermal growth factor receptor (EGFR)-targeted therapies in mesotheliomaPuey Ling Chia, Andrew M Scott, Thomas John
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 30, 2017
The utility of routine pre-chemotherapy screening with cardiac gated blood pool scan for patients at low risk of anthracycline toxicityPuey Ling Chia, K Chiang, R Snyder, et al.
Clinical Epidemiology|November 28, 2014
Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitorsPuey Ling Chia, Paul Mitchell, Alexander Dobrovic, et al.
Expert Review of Anticancer Therapy|October 5, 2016
Targeting the vasculature: anti-angiogenic agents for malignant mesotheliomaPuey Ling Chia, Prudence A Russell, Andrew M Scott, et al.
Journal of the National Cancer Institute|June 2, 2016
Current and Evolving Methods to Visualize Biological Data in Cancer ResearchPuey Ling Chia, Craig Gedye, Paul C Boutros, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Temporal changes of EGFR mutations and T790M levels in tumour and plasma DNA following AZD9291 treatmentPuey Ling Chia, Hongdo Do, Adrienne Morey, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2020
Analysis of angiogenic and stromal biomarkers in a large malignant mesothelioma cohortPuey Ling Chia, Prudence Russell, Khashi Asadi, et al.
Expert Review of Anticancer Therapy|August 8, 2023
Management of Oncogene Driven Locally Advanced Unresectable Non-small Cell Lung CancerJerold Loh, Jia Li Low, Manavi Sachdeva, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 11, 2016
Severe Psoriasis Flare After Anti-Programmed Death Ligand 1 (PD-L1) Therapy for Metastatic Non-Small Cell Lung Cancer (NSCLC)Puey Ling Chia, Thomas John
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 21, 2018
Personalized Chemosensitivity Assays for Mesothelioma: Are They Worth the Effort?Thomas John, Puey Ling Chia
Expert Opinion on Drug Delivery|March 28, 2019
Epidermal growth factor receptor (EGFR)-targeted therapies in mesotheliomaPuey Ling Chia, Andrew M Scott, Thomas John
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 30, 2017
The utility of routine pre-chemotherapy screening with cardiac gated blood pool scan for patients at low risk of anthracycline toxicityPuey Ling Chia, K Chiang, R Snyder, et al.
Clinical Epidemiology|November 28, 2014
Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitorsPuey Ling Chia, Paul Mitchell, Alexander Dobrovic, et al.
Expert Review of Anticancer Therapy|October 5, 2016
Targeting the vasculature: anti-angiogenic agents for malignant mesotheliomaPuey Ling Chia, Prudence A Russell, Andrew M Scott, et al.
Journal of the National Cancer Institute|June 2, 2016
Current and Evolving Methods to Visualize Biological Data in Cancer ResearchPuey Ling Chia, Craig Gedye, Paul C Boutros, et al.
Lung Cancer (Amsterdam, Netherlands)|July 10, 2016
Temporal changes of EGFR mutations and T790M levels in tumour and plasma DNA following AZD9291 treatmentPuey Ling Chia, Hongdo Do, Adrienne Morey, et al.
Lung Cancer (Amsterdam, Netherlands)|October 9, 2020
Analysis of angiogenic and stromal biomarkers in a large malignant mesothelioma cohortPuey Ling Chia, Prudence Russell, Khashi Asadi, et al.
Expert Review of Anticancer Therapy|August 8, 2023
Management of Oncogene Driven Locally Advanced Unresectable Non-small Cell Lung CancerJerold Loh, Jia Li Low, Manavi Sachdeva, et al.
Pageof 2